This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,078.10, is for the delivery of HEPLISAV-B 20 MCG/0.5 ML SYRNG 0.5ML, a hepatitis B vaccine. The contract is a firm fixed-price delivery order, with a completion date of January 2, 2025. This award is not associated with a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp is the prime contractor and has no listed major subcontractors. The contract supports the DLA Troop Support Medical, which is responsible for procuring medical products and supplies for the U.S. military and veteran healthcare programs.
Generated 4/1/25, 9:44 AM